Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL) are not the same thing, but they are closely related diseases.
The main difference lies in the location and extent of disease involvement:

Chronic Lymphocytic Leukemia (CLL) primarily affects the blood and bone marrow, with high numbers of circulating malignant B cells (leukemia).

Small-cell lymphoma affects lymph nodes and lymphoid tissue, with fewer malignant B cells circulating in the blood (lymphoma).

Criel et al. 1996 Leukemia 10(5): 848-53
Martínez-Trillos et al. 2018 Leuk Lymphoma 59(10): 2318-2326

…

References (Sources)

Chronic lymphocytic leukaemia
Hallek et al. 2018 Lancet 391(10129): 1524-1537
Review
Ibrutinib and its use in the treatment of chronic lymphocytic leukemia
Frustaci et al. 2018 Future Oncology 14: 681-697
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia
García-Muñoz et al. 2018 Immunotherapy 10: 491–499
Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spread
Criel et al. 1996 Leukemia 10(5): 848-53
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Martínez-Trillos et al. 2018 Leuk Lymphoma 59(10): 2318-2326
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
Palazzo et al. 2018 J Immunology 200: 2304

AI Chat

7/1/2026

Chat with our artificial intelligence:

Links

Chronic lymphocytic leukemia - Wikipedia